Editorial: Schizophrenia and the epigenetic hypothesis

Epigenomics

Volumn 2, Issue 3, 2010, Pages 341-344

  Grayson, Dennis R ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; CANNABIS; CHLORPROMAZINE; DNA METHYLTRANSFERASE 1; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; PHENCYCLIDINE; SEROTONIN RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1;

BEHAVIOR; BIPOLAR DISORDER; BRAIN; CENTRAL NERVOUS SYSTEM; COGNITION; DNA METHYLATION; DRUG TARGETING; EDITORIAL; EPIGENETICS; GENE EXPRESSION REGULATION; HALLUCINATION; HUMAN; MENTAL DISEASE; NEUROTRANSMISSION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; SCHIZOPHRENIA; GENETIC EPIGENESIS; INTERNEURON; METABOLISM; PHYSIOLOGY; PYRAMIDAL NERVE CELL;

DNA METHYLATION; EPIGENESIS, GENETIC; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID; HUMANS; INTERNEURONS; PYRAMIDAL CELLS; SCHIZOPHRENIA;

EID: 77954113201     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.22     Document Type: Editorial

References (20)

1. Lisman JE, Coyle JT, Green RW et al.: Circuit based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234-242 (2008).
2. Howes OD, Kapur S: The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophrenia Bull. 35, 549-562 (2009).
3. Lewis DA, Hashimoto T: Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons. Int. Rev. Neurobiol. 78, 109-131 (2007).
4. 67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psych. 57, 1061-1069 (2000).
5. Chen Y, Sharma R P, Costa RH, Costa E, Grayson DR: On the epigenetic regulation of human reelin promoter expression. Nucleic Acids Res. 30, 2930-2939 (2002).
6. Guidotti A, Auta J, Davis JM et al.: GABAergic dysfunction in schizophrenia: a new treatment on the horizon. Psychopharmacology (Berl.) 180, 191-205 (2005).
7. Hashimoto T, Arion D, Unger T et al.: Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 13, 147-161 (2008).
8. Conn PJ, Lindsley C W, Jones CK: Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci. 30, 25-31 (2008).
9. Marek GJ, Behl B, Bespalov AY, Gross G et al.: Glutamatergic (N-methyl-D-aspartate receptor hypofrontality in schizophrenia: too little juice or miswired brain? Mol. Pharmacol. 77, 317-326 (2010).
10. Belforte JE, Zsiros V, Sklar ER et al.: Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 13, 76-83 (2010).
11. Veldic M, Caruncho HM, Liu WS et al.: DNA-methyltransferase-1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl Acad. Sci. USA 101, 348-353 (2004).
12. Veldic M, Guidotti A, Maloku E, Davis JM, Costa E: In psychosis, cortical interneurons overexpress DNA-methyltransferase I. Proc. Natl Acad. Sci. USA 102, 2152-2157 (2005).
13. Ruzika W, Zhubi A, Veldic M, Grayson DR, Costa E, Guidotti A: Selective epigenetic alteration of Layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection. Mol. Psychiatry 12, 385-397 (2007).
14. Lewis DA, Hashimoto T, Volk DW: Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 6, 312-324 (2005).
15. Mill J, Tang T, Kaminsky Z et al.: Epigenomic profling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 82, 696-711 (2008).
16. Woo TUW, Walsh JP, Benes FM: Density of glutamic acid decarboxylase 67 messenger RNA containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar diorder. Arch. Gen. Psychiatry 61, 649-657 (2004).
17. Woo TUW, Kim AM, Viscidi E: Disease-specifc alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res. 1218, 267-277 (2008).
18. Huang HS, Akbarian S: GAD1 mRNA expression and DNA methylation in prefrontal cortex of subjects with schizophrenia. PLoS One 29, E809 (2007).
19. Akbarian S: The molecular pathology of schizophrenia-focus on histone and DNA modifcations. Brain Res. Bull. DOI:10.1016/j.brainresbull.2009.08.018 (2009) (Epub ahead of print).
20. Grayson DR, Kundakovic M, Sharma RP: Is there a future for HDAC inhibitors in the pharmacotherapy for psychiatric disorders? Mol. Pharmacol. 77, 126-135 (2010).